Salem Hospital is a non-profit, regional medical center located in Salem, Oregon, United States. Founded in 1896, the hospital has 454 beds. A Level II trauma center, the community hospital is the largest private employer in Salem and the only hospital in the city.

There are 454 beds in Salem Hospital.

During the past decade, Salem Hospital conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 34 clinical trials were completed, i.e. on average, 170% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 20 clinical trials were completed. i.e. 285.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Salem Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 21 trials, followed by "SWOG Cancer Research Network" with 17 trials sponsored, "Boston Scientific Corporation" with 3 trials sponsored, "Novartis Pharmaceuticals" with 2 trials sponsored and "Alliance for Clinical Trials in Oncology" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Salem Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 21 trials as a collaborator, "NRG Oncology" with 6 trials as a collaborator, "NCIC Clinical Trials Group" with 5 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator and "SWOG Cancer Research Network" with 4 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Salem Hospital" are "Recurrent Squamous Cell Lung Carcinoma" (7 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (6 trials), "Stage IV Lung Cancer AJCC v8" (4 trials), "Stage IVA Lung Cancer AJCC v8" (4 trials) and "Stage IVB Lung Cancer AJCC v8" (4 trials). Many other conditions were trialed in "Salem Hospital" in a lesser frequency.

Most popular intervention types in "Salem Hospital" are "Drug" (39 trials), "Other" (25 trials), "Biological" (16 trials), "Radiation" (7 trials) and "Procedure" (6 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (19 trials), "Quality-of-Life Assessment" (11 trials), "Docetaxel" (8 trials), "Bevacizumab" (6 trials) and "Paclitaxel" (5 trials). Other intervention names were less common.

The vast majority of trials in "Salem Hospital" are 44 trials for "All" genders, 4 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Salem Hospital". undefined are not yet recruiting, 4 are recruiting, 20 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in Salem Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Salem Hospital, 0 "Phase 1" clinical trials were conducted, 22 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".

Salem Hospital has several departments that took part in Clinical trials: "Salem Hospital Regional Cancer Care Services" - 29 trials